Philippe Delagrange

According to our database, Philippe Delagrange authored at least 3 papers between 2009 and 2022.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of four.

2022

Mathematical modeling of the microtubule detyrosination/tyrosination cycle for cell-based drug screening design.

Jeremy Grignard, Véronique Lamamy, Eva Vermersch, Philippe Delagrange, Jean-Philippe Stephan, Thierry Dorval, François Fages

PLoS Comput. Biol., 2022

2010

Receptor- and Ligand-Based Study on Novel 2, 2′-Bithienyl Derivatives as Non-Peptidic AANAT Inhibitors.

Alban Lepailleur, Stéphane Lemaître, Xiao Feng, Jana Sopkova-de Oliveira Santos, Philippe Delagrange, Jean Boutin, Pierre Renard, Ronan Bureau, Sylvain Rault

J. Chem. Inf. Model., 2010

2009

IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels.

Anthony J. Harmar, Rebecca A. Hills, Edward M. Rosser, Martin Jones, Oscar Peter Buneman, Donald R. Dunbar, Stuart D. Greenhill, Valerie A. Hale, Joanna L. Sharman, Tom I. Bonner, William A. Catterall, Anthony P. Davenport, Philippe Delagrange, Colin T. Dollery, Steven M. Foord, George A. Gutman, Vincent Laudet, Richard R. Neubig, Eliot H. Ohlstein, Richard W. Olsen, John A. Peters, Jean-Philippe Pin, Robert R. Ruffolo, David B. Searls, Mathew W. Wright, Michael Spedding

Nucleic Acids Res., 2009